Sterility assurance in cell therapy products

In this webinar, Dr Tim Sandle considers sterility assurance principles, rapid microbiological methods, environmental monitoring and much more.

 

 

Cellular therapy products represent a new wave in pharmaceuticals and include cellular immunotherapies, cancer vaccines and other types of both autologous and allogeneic cells for certain therapeutic indication. While the products are novel, sterility assurance concerns remain fundamental.

 

Send us an enquiry
+44 (0) 118 918 4000
lifesciencesales@rssl.com
Send an enquiry Send an enquiry
Topic areas we cover include:
  • Sterility assurance principles
  • Sterility testing
  • Rapid microbiological methods
  • Environmental monitoring
  • Facility, equipment, raw materials, test system, and personnel
  • Control of the collection, processing, packaging, and distribution of cell products

Register for this on demand webinar

Register now Register now
About the speaker:

 

 

Dr. Tim Sandle has over twenty-five years’ experience of microbiological research and biopharmaceutical processing. He is a member of several editorial boards and he has written over six hundred book chapters, peer reviewed papers and technical articles relating to microbiology. Dr. Sandle works for a pharmaceutical manufacturer in the UK, and is a visiting tutor at both the University of Manchester and UCL.

Need to contact us? Get help or ask us a question

Send an enquiry Send an enquiry